Infectious Disease: ExPECting the Worst

por Phillips, Melissa Lee
Publicado 2005

Children’s Centers Study Kids and Chemicals

por Phillips, Melissa Lee
Publicado 2005

Infectious Disease: New Human Retroviruses

por Phillips, Melissa Lee
Publicado 2005

Parkinson Disease: PD Gene and Oxidative Stress

por Phillips, Melissa Lee
Publicado 2006

Registering Skepticism: Does the EPA’s Pesticide Review Protect Children?

por Phillips, Melissa Lee
Publicado 2006

Obstructing Authority: Does the EPA Have the Power to Ensure Commercial Chemicals Are Safe?

por Phillips, Melissa Lee
Publicado 2006

Phthalates and Metabolism: Exposure Correlates with Obesity and Diabetes in Men

por Phillips, Melissa Lee
Publicado 2007

Dengue Reborn: Widespread Resurgence of a Resilient Vector

por Phillips, Melissa Lee
Publicado 2008

Gut Reaction: Environmental Effects on the Human Microbiota

por Phillips, Melissa Lee
Publicado 2009

Opinion: Multi-Mycotoxin Reference Materials

por Zhang, Kai, Phillips, Melissa
Publicado 2022

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges

por Phillips, Melissa M., Sheaff, Michael T., Szlosarek, Peter W.
Publicado 2013

Biliary Leak in Post-Liver-Transplant Patients: Is There Any Place for Metal Stent?

por Martins, Fernanda P., Phillips, Melissa, Gaidhane, Monica R., Schmitt, Timothy, Kahaleh, Michel
Publicado 2012

Determination of Curcuminoids in Turmeric Dietary Supplements by HPLC-DAD: Multi-laboratory Study Through the NIH-ODS/NIST Quality Assurance Program

por Mudge, Elizabeth M, Brown, Paula N, Rimmer, Catherine A, Phillips, Melissa M
Publicado 2020

DIGITAL NIST: An examination of the obstacles and opportunities in the digital transformation of NIST’s reference materials

por Camara, William Dinis, Choquette, Steven, Delak, Katya, Hanisch, Robert, Long, Benjamin, Phillips, Melissa, Ragland, Jared M., Rimmer, Catherine
Publicado 2023

Role of 3'-Deoxy-3'-[(18)F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers...

por Szyszko, Teresa A., Dunn, Joel T., Phillips, Melissa M., Bomalaski, John, Sheaff, Michael T., Ellis, Steve, Pike, Lucy, Goh, Vicky, Cook, Gary J.R., Szlosarek, Peter W.
Publicado 2022

A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma

por Chan, Pui Ying, Phillips, Melissa M., Ellis, Stephen, Johnston, Amanda, Feng, Xiaoxing, Arora, Amit, Hay, Gordon, Cohen, Victoria M. L., Sagoo, Mandeep S., Bomalaski, John S., Sheaff, Michael T., Szlosarek, Peter W.
Publicado 2022

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mech...

por Szlosarek, Peter W., Phillips, Melissa M., Pavlyk, Iuliia, Steele, Jeremy, Shamash, Jonathan, Spicer, James, Kumar, Sanjeev, Pacey, Simon, Feng, Xiaoxing, Johnston, Amanda, Bomalaski, John, Moir, Graeme, Lau, Kelvin, Ellis, Stephen, Sheaff, Michael
Publicado 2020

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

por Phillips, Melissa M., Pavlyk, Iuliia, Allen, Michael, Ghazaly, Essam, Cutts, Rosalind, Carpentier, Josephine, Berry, Joe Scott, Nattress, Callum, Feng, Shenghui, Hallden, Gunnel, Chelala, Claude, Bomalaski, John, Steele, Jeremy, Sheaff, Michael, Balkwill, Frances, Szlosarek, Peter W.
Publicado 2023

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

por Phillips, Melissa M., Pavlyk, Iuliia, Allen, Michael, Ghazaly, Essam, Cutts, Rosalind, Carpentier, Josephine, Berry, Joe Scott, Nattress, Callum, Feng, Shenghui, Hallden, Gunnel, Chelala, Claude, Bomalaski, John, Steele, Jeremy, Sheaff, Michael, Balkwill, Frances, Szlosarek, Peter W.
Publicado 2023

Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer

por Szlosarek, Peter W., Wimalasingham, Akhila G., Phillips, Melissa M., Hall, Peter E., Chan, Pui Ying, Conibear, John, Lim, Louise, Rashid, Sukaina, Steele, Jeremy, Wells, Paula, Shiu, Chiung‐Fang, Kuo, Chih‐Ling, Feng, Xiaoxing, Johnston, Amanda, Bomalaski, John, Ellis, Stephen, Grantham, Marianne, Sheaff, Michael
Publicado 2021